Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19.

Mesenchymal stem cells (MSC) have received particular attention due to their ability to inhibit inflammation caused by cytokine storm induced by COVID-19. In this way some patients have been treated successfully. The aim of this study was to evaluate the safety and describe the clinical changes after IV administration of allogeneic human umbilical cord MSC (ahUCMSC), in patients with bilateral pneumonia caused by COVID-19, complicated with severe ARDS, as compassionate treatment. This was a pilot, open-label, prospective, longitudinal study. Five patients that did not improve in their clinical conditions after 48 hours of receiving the standard medical management used by the Medical Center and with persistent PaO2/FiO2 less than 100 mmHg were enrolled. ahUCMSC were infused IV, at dose of 1x106 per Kg of body weight over 15 minutes. Patients were monitored after the infusion to detect adverse event. Pa02/FiO2, vital signs, D-dimer, C reactive protein and total lymphocytes were monitored for 21 days after the infusion or until the patient was discharged from the hospital. Descriptive statistics were used with means or medians and standard deviation or interquartile range according to the type of variable. The Wilcoxon's rank-sum was used for stationary samples. Adverse events occurred in three patients and were easily and quickly controlled. Immediately after the infusion of ahUCMSC, constant rise of PaO2/FiO2 was observed in all patients during the first 7 days, with statistical significance. Three patients survived and were extubated on the ninth day post-infusion. Two patients died at 13 and 15 days after infusion. The infusion of ahUCMSC in patients with severe ARDS caused by COVID-19, was safe, and demonstrated its anti-inflammatory capacity in the lungs, by improving the respiratory function expressed by PaO2 / FiO2, which allowed the survival of 3 patients, with extubation at 9 days.

Experience and management of two paediatric patients infected with SARS-CoV-2 with major burn injuries in an intensive care unit / Experiencia y manejo de dos pacientes pediátricos grandes quemados e infección por SARS-CoV-2 en una unidad de cuidados intensivos

RESUMEN La infección por SARS-CoV-2 se ha diseminado rápidamente, provocando una pandemia mundial en la cual nos vemos afectados. En el Instituto Nacional de Salud del Niño de San Borja, centro de referencia nacional de pacientes pediátricos quirúrgicos, desde el 14 de abril al 12 de agosto del 2020, se hospitalizaron 106 pacientes con infección por SARS-CoV-2, de los cuales 11 tuvieron diagnostico quemadura y dos fueron pacientes grandes quemados con diagnóstico COVID-19 por prueba molecular. Detallamos el caso de una paciente pediátrica, de siete años, gran quemada que fue atendida en unidad de cuidados intensivos, y con COVID-19 asintomática, presentó evolución y pronóstico favorable, con recuperación total de su lesión. Por otro lado, el COVID-19 se puede manifestar de forma severa produciendo un síndrome inflamatorio multisistémico que presenta manifestaciones clínicas poco comunes y que puede empeorar el pronóstico, como fue observado en nuestro otro paciente de siete meses que falleció pese a recibir manejo especializado y oportuno.

ABSTRACT SARS-CoV-2 infection is rapidly disseminating, leading to a world pandemics in which we are also affected. In San Borja Peruvian National Children Health Institute, which is the reference center for surgical pediatric patients, 106 patients infected with SARS-CoV-2 were hospitalized. Of them, 11 presented with burns and two had large burns. The viral infection was diagnosed using molecular testing. We present in detail the case of a pediatric seven-year old patient who had large burns and was taken care of in the intensive care unit. She had asymptomatic SARS-CoV-2 infection, and her outcome was good, with a good prognosis, and she recovered completely and uneventfully. On the other hand, COVID-19 may present as a severe disease leading to a multi- systemic inflammatory syndrome with some uncommon clinical manifestations which affect its prognosis , as it was the case with another seven-month old patient who passed away in spite of having received specialized and timely therapy.